Juno Pharmaceuticals Revenue and Competitors

South Yarra,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Juno Pharmaceuticals's estimated annual revenue is currently $6M per year.(i)
  • Juno Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Juno Pharmaceuticals has 30 Employees.(i)
  • Juno Pharmaceuticals grew their employee count by -12% last year.

Juno Pharmaceuticals's People

NameTitleEmail/Phone
1
Clinical Implementation ManagerReveal Email/Phone
2
National Account ManagerReveal Email/Phone
3
Marketing and Portfolio LeadReveal Email/Phone
4
National Sales ManagerReveal Email/Phone
5
Senior Regulatory Affairs AssociateReveal Email/Phone
6
Medical Information AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Juno Pharmaceuticals?

We are Juno Pharmaceuticals, an Australian leader in the hospital and specialty post‑patent pharma market, led by a team of innovative thinkers, passionate about supporting hospitals and healthcare specialists with the supply of off‑patent pharmaceuticals. We take an energetic approach to positively disrupt the status quo as we develop new ways to engage customers and identify opportunities. We strive to continually improve the way we work, operating at roots level within the local market to improve the development and delivery of pharmaceuticals within the healthcare industry.

keywords:N/A

N/A

Total Funding

30

Number of Employees

$6M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Juno Pharmaceuticals News

2022-04-17 - Mantle Cell Lymphoma Previously Treated With BTK Inhibitor ...

... Genentech, InnoCare, Janssen, Juno Therapeutics, Kite Pharma, ... Mumbai Hematology Group, Newbridge Pharmaceuticals, OMI, OncLive,...

2022-04-17 - Pharmacia's Dynastat patent expires before injunction ordered ...

... the decision in Pharmacia LLC v Juno Pharmaceuticals Pty Ltd [2022] ... Court found certain batches of Juno's generic parecoxib products...

2022-04-06 - ACCC to deny authorisation for pharmaceutical patent ...

... of an intellectual property settlement and licence agreement lodged by Juno Pharmaceuticals Pty Ltd (Juno) and Natco Pharma Ltd (Natco),...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M36-10%N/A
#2
$4.8M4111%N/A
#3
$8M599%N/A
#4
$13.3M5913%N/A
#5
$11.1M609%N/A